The biotechnology industry has always faced challenges around patent protection and drug launches. Factors include increasing competition, high costs for developing new drugs, and shortening times to peak sales. This case study demonstrates the impact of a Salesforce solution for a drug launch strategy. Our client harnessed the power of Salesforce to streamline and optimise the process of new drugs from lab to market. By integrating customised Salesforce functionalities into the drug launch strategy, our client gained the ability to identify and monitor drug safety trends.
A leading international biotech company known for its groundbreaking work in pharmaceuticals and diagnostics. The company is a pioneer in healthcare innovation, focused on developing new medicines and diagnostic tools that significantly improve patient outcomes.
Thanks to its involvement in research and development, it has an extensive portfolio of products in oncology, immunology, infectious diseases, ophthalmology and neurology.
Our client needed a system that would document the process of carrying a drug through all stages of clinical trials, from the Early Development phase until the drug is introduced to the market – Lifecycle/Established and post-marketed phase.
The requirements also included:
- Creation and implementation of a fully validated, signal/risk-aware tool for part of the organisation.
- Advanced and non-standard reporting needs (size, scope, volume of data).
- The specific, complicated and quite long validation process.
Craftware implemented a fully custom, validated system called Signal Tracking for managing signals, reports and actions, ensuring the signal-tracking process from beginning to end.
- Process coverage for drugs available on the market and under testing.
- Coverage of several business processes and workflows.
Integrations:
- The integration with The Empirica application was part of the project. Empirica collects alerts and reports from various sources. Alerts and reports are then forwarded to Signal Tracking as Alerts and are grouped into uniform Signals in the Signal Tracking system (a Signal may be several Alerts related to the same reported adverse drug reaction, ADR).
- The Signal is associated with a specific drug in the system.
- Documentation and all activities related to the Signal are also collected under the same drug.
- Risks and Actions are created and assigned to specific Users.
- Side effects reports can also be sent directly to the Signal Tracking system via web services.
- Another key integration is with SDR – an extensive reporting system that retrieves data from Signal Tracking via API issued by Salesforce and creates reports from this data). Reports are also partially created on the Salesforce platform and in Tableau and SAP Business Objects (BO).
Salesforce technology supports our clients’ organisations in managing the complex process of bringing drugs to the market. The success of this project strengthens our client’s position as a leader in healthcare innovation.
- The system allows for the identification and monitoring of drug safety trends.
- It helps to conduct activities related to drug safety supervision.
- It provides the analysis of both drug/event correlations and drug/drug interactions.
- It enables the detection of issues that may have been missed during clinical development.
As we look towards the future, it is clear that embracing such technological advancements is not just beneficial but essential for companies striving to excel in the competitive and dynamic realm of pharmaceuticals and diagnostics.
We invite you to consider the transformative potential of such systems for your organisation.
Natalia Wantuch
Explore more resources
-
From inquiry to swift response. Optimising Biotech communication with CRM solutions for drug inquiries and notifications
-
Managing marketing materials across the biopharma company thanks to the application built on Salesforce
-
Faster customer service and improved customer experience in a life science company
